Navigation Links
Valeant Pharmaceuticals Responds to Cephalon Board's Letter
Date:4/21/2011

nal specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of neurology, dermatology and branded generics. More information about Valeant can be found at www.valeant.com.

Forward-looking Statements

Certain statements made in this press release may constitute forward-looking statements of Valeant, including, but not limited to, statements regarding our offer to purchase Cephalon, financing related to the proposed transaction, our consent solicitation process or our intention to commence a tender offer, our opportunities and our plans should we acquire Cephalon, the effect of the proposed transaction on financial results, and certain financial projections.  Forward-looking statements may be identified by the use of the words "anticipates," "expects," "intends," "plans," "should," "could," "would," "may," "will," "believes," "estimates," "potential," or "continue" and variations or similar expressions.  These statements are based upon the current expectations and beliefs of management of Valeant and are subject to certain risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements.  These risks and uncertainties include, but are not limited to, risks and uncertainties discussed in Valeant's most recent annual or quarterly report filed with the Securities and Exchange Commission ("SEC") and Canadian Securities Administrators ("CSA") and other risks and uncertainties as discussed from time to time in Valeant's filings with the SEC and the CSA, which disclosures are incorporated herein by reference.  Readers are cautioned not to place undue reliance on any of these forward-looking statements.  Valeant undertakes no obligation to update any of these forward-looking statements to reflect events or circumstances after the date of this press r
'/>"/>

SOURCE Valeant Pharmaceuticals International, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Valeant Pharmaceuticals Announces Redemption of 4.0% Convertible Subordinated Notes Due 2013
2. Regulatory Update - GSK and Valeant Respond to FDA on ezogabine
3. Valeant Pharmaceuticals Adds Corporate Governance Expert Abe Friedman to its Slate of Proposed Cephalon Directors
4. Valeant Pharmaceuticals Files Presentation for Cephalon Stockholders
5. Valeant Pharmaceuticals Files Preliminary Consent Solicitation Statement With the SEC
6. Promius Pharma and Valeant Form Collaboration to Market Cloderm® Cream in the United States
7. Valeant Pharmaceuticals Proposes to Acquire Cephalon, Inc. for $73 Per Share in Cash
8. GSK and Valeant Receive European Authorisation for Trobalt (retigabine)
9. Valeant Pharmaceuticals Extends Contract with J. Michael Pearson as CEO and Appoints Him as Chairman of the Board
10. Valeant Pharmaceuticals Completes Acquisition of PharmaSwiss S.A.
11. Valeant Announces Pricing of Senior Notes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... , July 23, 2014 UBM Medica ... – a new online community and information resource for ... manage and treat their patients with neurological disorders ... with an aging population, necessitates greater access to dedicated ...  Key statistics on neurological conditions include: , ...
(Date:7/23/2014)... Calif. , July 23, 2014 Pharmavite ... the company,s chief customer officer effective immediately. Toll recently ... customer sales and marketing, category management, private label and ... . In his new global role, Toll will expand ... global sales planning. "Toll,s appointment to chief ...
(Date:7/23/2014)... Research and Markets   has ... Ablation Catheters Market 2014-2018" report to their ... Catheter ablation is a minimally invasive ... pathways from sections of the heart that promote ... Cardiac arrhythmias can be of several types, including ...
Breaking Medicine Technology:UBM Medica US Launches NeurologyTimes.com 2UBM Medica US Launches NeurologyTimes.com 3Global Electrophysiology Ablation Catheters Market 2014-2018: Key Vendors are Boston Scientific, Johnson & Johnson, Medtronic and St. Jude Medical 2Global Electrophysiology Ablation Catheters Market 2014-2018: Key Vendors are Boston Scientific, Johnson & Johnson, Medtronic and St. Jude Medical 3
... 2011 Amgen (NASDAQ: AMGN ) reported total ... to $3,959 million versus $3,804 million in the second quarter ... second quarter of 2011 to $3,893 million versus $3,613 million ... revenue in the second quarter of 2011 included a decline ...
... ENCINITAS, Calif., July 28, 2011 /PRNewswire-iReach/ -- Encinitas, CA-based ... the 2011 season in full focus with today,s launch of their ... E N invites the World Wide Web to explore art, culture, ...   http://photos.prnewswire.com/prnh/20110728/CG43745 ) THE LOOK ...
Cached Medicine Technology:Amgen’s Second Quarter 2011 Revenue Increased 4 Percent to $4.0 Billion 2Amgen’s Second Quarter 2011 Revenue Increased 4 Percent to $4.0 Billion 3Amgen’s Second Quarter 2011 Revenue Increased 4 Percent to $4.0 Billion 4Amgen’s Second Quarter 2011 Revenue Increased 4 Percent to $4.0 Billion 5Amgen’s Second Quarter 2011 Revenue Increased 4 Percent to $4.0 Billion 6Amgen’s Second Quarter 2011 Revenue Increased 4 Percent to $4.0 Billion 7Amgen’s Second Quarter 2011 Revenue Increased 4 Percent to $4.0 Billion 8Amgen’s Second Quarter 2011 Revenue Increased 4 Percent to $4.0 Billion 9Amgen’s Second Quarter 2011 Revenue Increased 4 Percent to $4.0 Billion 10Amgen’s Second Quarter 2011 Revenue Increased 4 Percent to $4.0 Billion 11Amgen’s Second Quarter 2011 Revenue Increased 4 Percent to $4.0 Billion 12Amgen’s Second Quarter 2011 Revenue Increased 4 Percent to $4.0 Billion 13Amgen’s Second Quarter 2011 Revenue Increased 4 Percent to $4.0 Billion 14Amgen’s Second Quarter 2011 Revenue Increased 4 Percent to $4.0 Billion 15Amgen’s Second Quarter 2011 Revenue Increased 4 Percent to $4.0 Billion 16Amgen’s Second Quarter 2011 Revenue Increased 4 Percent to $4.0 Billion 17Amgen’s Second Quarter 2011 Revenue Increased 4 Percent to $4.0 Billion 18Amgen’s Second Quarter 2011 Revenue Increased 4 Percent to $4.0 Billion 19R A E N Optics Launches New Website and Releases New Styles 2
(Date:7/24/2014)... 2014 Crawford Technologies today announced ... partnership with AIIM, focusing on global trends in ... of the survey indicated that even though organizations ... for customer service, legal and regulatory compliance and ... save exact facsimiles of these documents. , The ...
(Date:7/24/2014)... Freeslate, Inc ., the leading ... development, today announced its feature in the BioProcess ... Kling. Topics of this article include problematic ... automation can help address many of these problems. ... a growing focus of pharmaceutical organizations in recent ...
(Date:7/24/2014)... NE and Ft. Lauderdale, FL (PRWEB) July 24, ... an agreement to provide a wide range of ... nationwide. Under the agreement, BMG member practices can ... , “Blackmaple GroupPurchasing Solutions is growing rapidly, building ... Cooper, Partner. “Our approach is to offer deep ...
(Date:7/23/2014)... (PRWEB) July 23, 2014 The discounts ... and beauty products do not include various skin creams ... now revealing skin tightening cream discounts inside of its ... The guide is now available to offer a direct ... recently released products available for sale. Although the guide ...
(Date:7/23/2014)... The age spots, wrinkles and puffy eyes that can be ... now explored in a new guide posted at the Cherry ... over 30 are introduced in the guide as well as ... of creams as an alternative to surgery is one method ... the information in the new guide. Because there are hundreds ...
Breaking Medicine News(10 mins):Health News:AIIM Research Shows 56% of Organizations Not Utilizing Digital Archiving Technology 2Health News:AIIM Research Shows 56% of Organizations Not Utilizing Digital Archiving Technology 3Health News:AIIM Research Shows 56% of Organizations Not Utilizing Digital Archiving Technology 4Health News:Freeslate Featured in BioProcess International Article Discussing Challenges and Solutions to Highly Concentrated Protein Formulations 2Health News:Freeslate Featured in BioProcess International Article Discussing Challenges and Solutions to Highly Concentrated Protein Formulations 3Health News:Seacoast Medical Partners with Blackmaple Group to Provide Members Cost Savings on Wide Range of Pharmaceutical Products 2Health News:Skin Tightening Cream Discounts Revealed in New Cost Saving Guide at Consumer Portal 2Health News:Best Eye Creams for Women Over 30 Detailed in Published Guide at News Website Online 2
... Arunachal Pradesh have rediscovered a rare medicinal plant after more ... Botanical Survey of India spotted the wild flower, Begonia Tessaricarpa, ... northeastern state's Upper Subansari district bordering China. ... found the flower blooming in a narrow strip of rocky ...
... A three-day yagna-fire worship-with 1,000 pyres began Friday here to ... ,Amid chanting of Vedic hymns by Hindu priests from ... heads, the ritual was performed with the lighting of a ... Eastern Railway near here. ,The yagna, organised by ...
... are conducted periodically to check fitness in students. Jack ... year's results of the annual assessment of fifth, seventh ... the fifth, seventh and ninth graders and studies student ... the test this year. Only one-third could meet the ...
... been benefited by occupational therapy which helped them to ... //improving as well as helping their caregivers, according to ... hikes up costs of health-care and social services in ... of this disease. Besides, current drugs do not improve ...
... is causing eating disorders among several patients, according to ... Improvement Scotland (NHS QIS) added that the 'myths' available ... by thousands of Scots afflicted with conditions like anorexia ... have been issued by the health watch dog for ...
... fever has killed 44 people in Pakistan and forced nearly ... ministry, 4,866 people with symptoms similar to dengue fever have ... 1,724 of them have tested positive for the virus. ... and one in the North West Frontier province. ...
Cached Medicine News:Health News:Medicinal Plant Rediscovered After 115 Years 2Health News:Task therapy Beneficial to Patients with Dementia 2Health News:Internet Health Advice Causing More Harm than Good 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: